Target intelligence / Profile preview

Nuclear factor kappa-light-chain-enhancer of activated B cells subunit p65 (NF-κB p65 or RELA)

Target
NF-κB p65 or RELA
Molecular classification
Transcription factor
01

Overview

Nuclear factor kappa-light-chain-enhancer of activated B cells subunit p65 (NF-κB p65 or RELA) is a transcription factor crucial for immune responses, inflammation, cell survival, and proliferation. It is part of the NF-κB complex, which is involved in various signaling pathways and is activated by diverse stimuli such as cytokines, stress, and bacterial or viral antigens. Misregulation of NF-κB has been linked to cancer, autoimmune diseases, and inflammatory conditions.

Other names
Transcription factor p65Nuclear factor NF-kappa-B p65 subunitNF-kappa B p65 SubunitRELAv-Rel reticuloendotheliosis viral oncogene homolog A
02

Mechanism of action

Drugs targeting NF-κB p65 typically work by inhibiting its activity, which can reduce inflammation and immune response.

03

Biological functions

Signal transductionImmune responseCell survivalApoptosis regulationInflammationCell proliferationCell death regulation
04

Disease associations

CancerInflammationInfectionAutoimmune diseasesNeurodegenerative disease
05

Safety considerations

ImmunosuppressionIncreased susceptibility to infections
06

Interacting drugs

Glucocorticoids

1 more in the full profile.

07

Biomarkers

Presence of phosphorylated IκBαLevels of NF-κB-dependent genes

Beyond the preview

Go deeper on Nuclear factor kappa-light-chain-enhancer of activated B cells subunit p65 (NF-κB p65 or RELA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear factor kappa-light-chain-enhancer of activated B cells subunit p65 (NF-κB p65 or RELA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call